Literature DB >> 12749822

Involvement of MEK/ERK pathway in cephaloridine-induced injury in rat renal cortical slices.

Yuka Kohda1, Jun Hiramatsu, Munekazu Gemba.   

Abstract

We have previously reported that free radical-mediated injury induced by cephaloridine (CER) is enhanced by phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, in rat renal cortical slices. We have also shown that PKC activation in mitochondria is involved in CER-induced nephrotoxicity in rats. We investigated the role of a downstream PKC pathway, a MEK/ERK pathway, in free radical-induced injury in rat renal cortical slices exposed to CER. Immediately after preparing slices from rat renal cortex, the slices were incubated in the medium containing MEK inhibitors. ERK1/2 activation was determined by Western blot analysis for phosphorylated ERK (pERK) 1/2 protein in nucleus fraction prepared from the slices exposed to CER. Prominently, CER caused not only increases in lipid peroxidation as an index of free radical generation and in LDH leakage as that of cell injury in the slices, but also marked activation of ERK1/2 in nucleus fraction. PD98059 and U0126, MEK1/2 inhibitors, significantly attenuated CER-induced increases in lipid peroxidation and LDH leakage in the slices. PD98059 also suppressed ERK1/2 activation in nucleus fraction prepared from the slices treated with CER. Inhibition of other MAP kinase pathways, p38 MAP kinase and c-Jun N-terminal kinase (JNK) had no effect on CER-induced increases in lipid peroxidation level and LDH leakage in the slices. The present results suggest that a MEK/ERK pathway down stream of a PKC pathway is probably involved in free radical-induced injury in rat renal cortical slices exposed to CER.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749822     DOI: 10.1016/s0378-4274(03)00174-7

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

1.  Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells.

Authors:  Grazyna Nowak; Ginger L Clifton; Malinda L Godwin; Diana Bakajsova
Journal:  Am J Physiol Renal Physiol       Date:  2006-05-16

2.  Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.

Authors:  Yifat Koren Carmi; Hatem Mahmoud; Hazem Khamaisi; Rina Adawi; Jacob Gopas; Jamal Mahajna
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 3.  ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.

Authors:  Reiko Sugiura; Ryosuke Satoh; Teruaki Takasaki
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.